March 31, 2014

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2014 ACS

Patent Number: WO 20140038943
Title: Azetidine derivatives and related compounds as serotonin receptor modulators and their preparation and use in the treatment of serotonin-mediated diseases
Inventor(s): Carruthers, Nicholas I.; Shireman, Brock T.; Tran, Vi T.; Wong, Victoria D.; Jablonowski, Jill A.; Chai, Wenying
Patent Assignee(s): Janssen Pharmaceutica N. V., Belg.
Source: PCT Int. Appl., 235pp. CODEN: PIXXD2
Language: English

Abstract:
The azetidines and related compds. of formula I are serotonin modulators useful in the treatment of serotonin-mediated diseases.  Compds. of formula I wherein R1 is H, C1-4 alkyl, monocyclic cycloalkyl, Ph and benzyl; A is (CHR2)n; B is (CHR3)m; m is 1, 2, and 3; n is 1 and 2; with proviso that if m is 2, then n is not 1; R2 and R3 are independently H and C1-4 alkyl; R4 is H, F, C1-4 alkyl; or R4 is OH when L is CH2, CF2, CHF, OCH2 and OCHCH3; L is O, CH2, OCH2, OCHCH3, CH2O, CF2, and CHF; Z is O, CO, OCH2, etc.; R5 is (un)substituted Ph, (un)substituted phenoxy, (un)substituted naphthyl, etc.; X is C and N; R6 and R7 are independently H, halo, CF3, thienyl, and CONH2 and derivs.; and pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, and pharmaceutically active metabolites thereof, are claimed. Example compd. II was prepd. by a multistep procedure (procedure given). All the invention compds. were evaluated for their serotonin receptor modulatory activity (data given).

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 

 View the full-text here.

Recent News


    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value

    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals

                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org